HRO761

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRO761, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. [Phase 1]

See pricing